TYP 5.26% 1.8¢ tryptamine therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-28

  1. 5,918 Posts.
    lightbulb Created with Sketch. 1830
    Markets are in for a bumpy 6 to 12 months IMO. However, the healthcare space is one that should do ok. I suspect we get 12 months of costs rising a bit and interest rates might tick up, but then things will level off. EX1 has plenty cash. I am a firm advocate of the story pushed by Cathie Wood that we will see a convergence of computer science, AI and medicine/genomics etc over the next 5 to 10 years that will transform healthcare just as the internet has transformed our lives since the 90's

    I fully expect good returns will be a while in coming here, but just because there is not much they can report I am extremely confident the team are working very hard in the background. This is a gem I'm not letting go of and ranks as one of my highest $ holdings
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
-0.001(5.26%)
Mkt cap ! $19.60M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $14.08K 743.8K

Buyers (Bids)

No. Vol. Price($)
1 500000 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 76164 1
View Market Depth
Last trade - 15.34pm 06/09/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.